Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2022	Apr. 02, 2021
Cash flows from operating activities:
Net earnings	$ 1,725	$ 1,702
Noncash items:
Depreciation	179	158
Amortization of intangible assets	386	344
Amortization of acquisition-related inventory fair value step-up	0	29
Stock-based compensation expense	80	54
Pretax gain on sale of product lines and investment (gains) losses	24	(102)
Change in trade accounts receivable, net	80	59
Change in inventories	(431)	(171)
Change in trade accounts payable	(131)	(38)
Change in prepaid expenses and other assets	(22)	239
Change in accrued expenses and other liabilities	78	(403)
Net cash provided by operating activities	1,968	1,871
Cash flows from investing activities:
Cash paid for acquisitions	(17)	(419)
Payments for additions to property, plant and equipment	(250)	(251)
Proceeds from sales of property, plant and equipment	2	12
Payments for purchases of investments	(274)	(420)
Proceeds from sales of investments	17	43
Proceeds from sale of product lines	0	26
All other investing activities	19	16
Total cash used in investing activities	(503)	(993)
Cash flows from financing activities:
Payments for the issuance of common stock in connection with stock-based compensation, net	(46)	(12)
Payment of dividends	(191)	(169)
Net proceeds from (repayments of) borrowings (maturities of 90 days or less)	10	(1)
Net repayments of borrowings (maturities longer than 90 days)	0	(279)
All other financing activities	(47)	12
Total cash used in financing activities	(274)	(449)
Effect of exchange rate changes on cash and equivalents	(60)	(134)
Net change in cash and equivalents	1,131	295
Beginning balance of cash and equivalents	2,586	6,035
Ending balance of cash and equivalents	3,717	6,330
Supplemental disclosures:
Cash interest payments	84	83
Cash income tax payments	$ 227	$ 122